Cohen Klingenstein’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.3M | Hold |
31,270
| – | – | 0.32% | 40 |
|
|
2026
Q1 | $11M | Hold |
31,270
| – | – | 0.36% | 37 |
|
|
2025
Q4 | $10.2M | Hold |
31,270
| – | – | 0.31% | 41 |
|
|
2025
Q3 | $8.82M | Hold |
31,270
| – | – | 0.28% | 45 |
|
|
2025
Q2 | $8.73M | Hold |
31,270
| – | – | 0.29% | 47 |
|
|
2025
Q1 | $9.74M | Hold |
31,270
| – | – | 0.35% | 39 |
|
|
2024
Q4 | $8.15M | Sell |
31,270
-1,750
| -5% | -$519K | 0.28% | 48 |
|
|
2024
Q3 | $10.6M | Hold |
33,020
| – | – | 0.37% | 47 |
|
|
2024
Q2 | $10.3M | Hold |
33,020
| – | – | 0.37% | 46 |
|
|
2024
Q1 | $9.39M | Hold |
33,020
| – | – | 0.35% | 47 |
|
|
2023
Q4 | $9.51M | Hold |
33,020
| – | – | 0.39% | 47 |
|
|
2023
Q3 | $8.87M | Hold |
33,020
| – | – | 0.4% | 46 |
|
|
2023
Q2 | $7.33M | Hold |
33,020
| – | – | 0.32% | 51 |
|
|
2023
Q1 | $7.98M | Hold |
33,020
| – | – | 0.37% | 49 |
|
|
2022
Q4 | $8.67M | Hold |
33,020
| – | – | 0.44% | 46 |
|
|
2022
Q3 | $7.44M | Hold |
33,020
| – | – | 0.39% | 46 |
|
|
2022
Q2 | $8.03M | Hold |
33,020
| – | – | 0.4% | 47 |
|
|
2022
Q1 | $7.99M | Hold |
33,020
| – | – | 0.33% | 56 |
|
|
2021
Q4 | $7.43M | Hold |
33,020
| – | – | 0.29% | 61 |
|
|
2021
Q3 | $7.02M | Hold |
33,020
| – | – | 0.31% | 62 |
|
|
2021
Q2 | $8.05M | Hold |
33,020
| – | – | 0.35% | 60 |
|
|
2021
Q1 | $8.22M | Hold |
33,020
| – | – | 0.38% | 55 |
|
|
2020
Q4 | $7.59M | Hold |
33,020
| – | – | 0.38% | 57 |
|
|
2020
Q3 | $8.39M | Hold |
33,020
| – | – | 0.47% | 46 |
|
|
2020
Q2 | $7.79M | Hold |
33,020
| – | – | 0.48% | 44 |
|
|
2020
Q1 | $6.69M | Hold |
33,020
| – | – | 0.5% | 43 |
|
|
2019
Q4 | $7.96M | Hold |
33,020
| – | – | 0.46% | 50 |
|
|
2019
Q3 | $6.39M | Hold |
33,020
| – | – | 0.4% | 57 |
|
|
2019
Q2 | $6.08M | Hold |
33,020
| – | – | 0.43% | 56 |
|
|
2019
Q1 | $6.27M | Hold |
33,020
| – | – | 0.44% | 51 |
|
|
2018
Q4 | $6.43M | Hold |
33,020
| – | – | 0.97% | 20 |
|
|
2018
Q3 | $6.84M | Hold |
33,020
| – | – | 0.87% | 18 |
|
|
2018
Q2 | $6.09M | Hold |
33,020
| – | – | 0.83% | 20 |
|
|
2018
Q1 | $5.63M | Hold |
33,020
| – | – | 0.8% | 23 |
|
|
2017
Q4 | $5.74M | Hold |
33,020
| – | – | 0.82% | 22 |
|
|
2017
Q3 | $6.16M | Hold |
33,020
| – | – | 0.93% | 21 |
|
|
2017
Q2 | $5.69M | Hold |
33,020
| – | – | 0.89% | 22 |
|
|
2017
Q1 | $5.42M | Hold |
33,020
| – | – | 0.87% | 23 |
|
|
2016
Q4 | $4.83M | Hold |
33,020
| – | – | 0.82% | 23 |
|
|
2016
Q3 | $5.51M | Hold |
33,020
| – | – | 0.96% | 21 |
|
|
2016
Q2 | $5.02M | Hold |
33,020
| – | – | 0.92% | 21 |
|
|
2016
Q1 | $4.95M | Hold |
33,020
| – | – | 0.93% | 21 |
|
|
2015
Q4 | $5.36M | Hold |
33,020
| – | – | 1% | 19 |
|
|
2015
Q3 | $4.57M | Hold |
33,020
| – | – | 0.9% | 23 |
|
|
2015
Q2 | $5.07M | Hold |
33,020
| – | – | 0.91% | 22 |
|
|
2015
Q1 | $5.28M | Hold |
33,020
| – | – | 0.96% | 22 |
|
|
2014
Q4 | $5.26M | Hold |
33,020
| – | – | 0.99% | 23 |
|
|
2014
Q3 | $4.64M | Hold |
33,020
| – | – | 0.82% | 26 |
|
|
2014
Q2 | $3.91M | Hold |
33,020
| – | – | 0.75% | 26 |
|
|
2014
Q1 | $4.07M | Hold |
33,020
| – | – | 0.81% | 25 |
|
|
2013
Q4 | $3.77M | Hold |
33,020
| – | – | 0.75% | 25 |
|
|
2013
Q3 | $3.7M | Hold |
33,020
| – | – | 0.81% | 25 |
|
|
2013
Q2 | $3.26M | Buy |
+33,020
| New | +$3.43M | 0.76% | 27 |
|
Other funds holding AMGN
FFM
SP
Cohen Klingenstein's AMGN Position: Q2 2026 in Review
Cohen Klingenstein held its Amgen (AMGN) position steady in Q2 2026 at 31,270 shares worth $11.3M. The position accounts for 0.32% of the portfolio, ranked #40.
Cohen Klingenstein first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cohen Klingenstein held 31,270 shares of Amgen worth $11.3M as of Q2 2026.
- Cohen Klingenstein left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.32% of Cohen Klingenstein's portfolio in Q2 2026, its #40 holding.
- Cohen Klingenstein first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.